141 related articles for article (PubMed ID: 15864607)
1. Effective antitumour mono- and combination therapy by gene delivery of angiostatin-like molecule and interleukin-12 in a murine hepatoma model.
Schmitz V; Tirado-Ledo L; Raskopf E; Rabe C; Wernert N; Wang L; Prieto J; Qian C; Sauerbruch T; Caselmann WH
Int J Colorectal Dis; 2005 Nov; 20(6):494-501. PubMed ID: 15864607
[TBL] [Abstract][Full Text] [Related]
2. Treatment of colorectal and hepatocellular carcinomas by adenoviral mediated gene transfer of endostatin and angiostatin-like molecule in mice.
Schmitz V; Wang L; Barajas M; Gomar C; Prieto J; Qian C
Gut; 2004 Apr; 53(4):561-7. PubMed ID: 15016752
[TBL] [Abstract][Full Text] [Related]
3. Additive antitumour response to the rabbit VX2 hepatoma by combined radio frequency ablation and toll like receptor 9 stimulation.
Behm B; Di Fazio P; Michl P; Neureiter D; Kemmerling R; Hahn EG; Strobel D; Gress T; Schuppan D; Wissniowski TT
Gut; 2016 Jan; 65(1):134-43. PubMed ID: 25524262
[TBL] [Abstract][Full Text] [Related]
4. IL-12 gene therapy is an effective therapeutic strategy for hepatocellular carcinoma in immunosuppressed mice.
Harada N; Shimada M; Okano S; Suehiro T; Soejima Y; Tomita Y; Maehara Y
J Immunol; 2004 Dec; 173(11):6635-44. PubMed ID: 15557154
[TBL] [Abstract][Full Text] [Related]
5. Improving immunotherapy of hepatocellular carcinoma (HCC) using dendritic cells (DC) engineered to express IL-12 in vivo.
Vogt A; Sievers E; Lukacs-Kornek V; Decker G; Raskopf E; Meumann N; Büning H; Sauerbruch T; Strassburg CP; Schmidt-Wolf IG; Gonzalez-Carmona MA
Liver Int; 2014 Mar; 34(3):447-61. PubMed ID: 23998316
[TBL] [Abstract][Full Text] [Related]
6. Low-dose adenoviral immunotherapy of rat hepatocellular carcinoma using single-chain interleukin-12.
Waehler R; Ittrich H; Mueller L; Krupski G; Ameis D; Schnieders F
Hum Gene Ther; 2005 Mar; 16(3):307-17. PubMed ID: 15812226
[TBL] [Abstract][Full Text] [Related]
7. Combined treatment of a murine breast cancer model with type 5 adenovirus vectors expressing murine angiostatin and IL-12: a role for combined anti-angiogenesis and immunotherapy.
Gyorffy S; Palmer K; Podor TJ; Hitt M; Gauldie J
J Immunol; 2001 May; 166(10):6212-7. PubMed ID: 11342643
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of hepatocellular carcinoma by transfecting interleukin-12 and interleukin-2 fusion gene intrasplenically, an experimental study].
Yang JH; Fan RF; Qian QJ; You TG; Xue HB; Su CQ; Cao HF; Wu MC
Zhonghua Yi Xue Za Zhi; 2003 May; 83(9):740-3. PubMed ID: 12899748
[TBL] [Abstract][Full Text] [Related]
9. Antiangiogenic therapy enhances the efficacy of transcatheter arterial embolization for hepatocellular carcinomas.
Jiang H; Meng Q; Tan H; Pan S; Sun B; Xu R; Sun X
Int J Cancer; 2007 Jul; 121(2):416-24. PubMed ID: 17330237
[TBL] [Abstract][Full Text] [Related]
10. Combined use of adenoviral vector Ad5/F35-mediated APE1 siRNA enhances the therapeutic efficacy of adenoviral-mediated p53 gene transfer in hepatoma cells in vitro and in vivo.
Cun Y; Zhang Q; Xiong C; Li M; Dai N; Zhang S; Wang D
Oncol Rep; 2013 Jun; 29(6):2197-204. PubMed ID: 23563597
[TBL] [Abstract][Full Text] [Related]
11. [Gene transfer of murine Flt3 ligand mediated by adenoviral vector efficiently induces growth inhibition of murine liver cancer].
Yang Q; Yang G; Wei L; Jia F; Wu M; Guo Y
Zhonghua Yi Xue Za Zhi; 2002 Jun; 82(11):775-9. PubMed ID: 12126551
[TBL] [Abstract][Full Text] [Related]
12. Intratumoural interleukin 12 gene therapy stimulates the immune system and decreases angiogenesis in dogs with spontaneous cancer.
Cicchelero L; Denies S; Haers H; Vanderperren K; Stock E; Van Brantegem L; de Rooster H; Sanders NN
Vet Comp Oncol; 2017 Dec; 15(4):1187-1205. PubMed ID: 27506827
[TBL] [Abstract][Full Text] [Related]
13. Plasminogen fragment K1-5 improves survival in a murine hepatocellular carcinoma model.
Schmitz V; Raskopf E; Gonzalez-Carmona MA; Vogt A; Rabe C; Leifeld L; Kornek M; Sauerbruch T; Caselmann WH
Gut; 2007 Feb; 56(2):271-8. PubMed ID: 16809420
[TBL] [Abstract][Full Text] [Related]
14. [Construction of a RU486 inducible recombinant adenoviral vector carrying murine interleukin-12 gene and experimental treatment of colonic carcinoma].
Chen J; Liu XS; Wang F; Xue XC; Fang GE; Su CQ; Qian QJ
Zhonghua Yi Xue Za Zhi; 2009 May; 89(20):1372-6. PubMed ID: 19671324
[TBL] [Abstract][Full Text] [Related]
15. Combined GM-CSF and IL-12 gene therapy synergistically suppresses the growth of orthotopic liver tumors.
Chang CJ; Chen YH; Huang KW; Cheng HW; Chan SF; Tai KF; Hwang LH
Hepatology; 2007 Mar; 45(3):746-54. PubMed ID: 17326190
[TBL] [Abstract][Full Text] [Related]
16. Adenoviral vectors expressing human endostatin-angiostatin and soluble Tie2: enhanced suppression of tumor growth and antiangiogenic effects in a prostate tumor model.
Raikwar SP; Temm CJ; Raikwar NS; Kao C; Molitoris BA; Gardner TA
Mol Ther; 2005 Dec; 12(6):1091-100. PubMed ID: 16169279
[TBL] [Abstract][Full Text] [Related]
17. Efficient delivery of angiostatin K1-5 into tumors following insertion of an NGR peptide into adenovirus capsid.
Jullienne B; Vigant F; Muth E; Chaligné R; Bouquet C; Giraudier S; Perricaudet M; Benihoud K
Gene Ther; 2009 Dec; 16(12):1405-15. PubMed ID: 19641530
[TBL] [Abstract][Full Text] [Related]
18. Effects of interleukin-2 transduction on the human hepatoma cell lines using retroviral vector.
Kim JH; Gong SJ; Yoo NC; Lee H; Shin DH; Uhm HD; Jeong SJ; Cho JY; Rha SY; Kim YS; Chung HC; Roh JK; Min JS; Kim BS
Oncol Rep; 1999; 6(1):49-54. PubMed ID: 9864400
[TBL] [Abstract][Full Text] [Related]
19. Intratumoral neoadjuvant immunotherapy using IL-12 and dendritic cells is an effective strategy to control recurrence of murine hepatocellular carcinoma in immunosuppressed mice.
Kayashima H; Toshima T; Okano S; Taketomi A; Harada N; Yamashita Y; Tomita Y; Shirabe K; Maehara Y
J Immunol; 2010 Jul; 185(1):698-708. PubMed ID: 20498356
[TBL] [Abstract][Full Text] [Related]
20. Gene transfer and therapy with adenoviral vector in rats with diethylnitrosamine-induced hepatocellular carcinoma.
Qian C; Idoate M; Bilbao R; Sangro B; Bruña O; Vázquez J; Prieto J
Hum Gene Ther; 1997 Feb; 8(3):349-58. PubMed ID: 9048202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
